Infection risk of rituximab monotherapy versus combination therapy with rituximab and mycophenolic acid in systemic sclerosis: A retrospective cohort study

JB Kang, KN Smith, EM Meara, M Cho, JD Silverman, AH LaChance, JS Smith

Abstract

Key words: complex medical dermatologyimmunomodulationinfectionmycophenolic acidrituximabsystemic sclerosis